More customer demand and a faster growth rate are exactly what Novo Nordisk needs to make this stock a buy again
The good news is these medications, semaglutide, the active ingredient in Ozempic and Wegovy, or tirzepatide, the active ingredient in Mounjaro, are part of a class of medications, GLP-1 receptor agonists, that have been around for over 20 years so we know the side effects, mostly gastrointestinal in nature (nausea, vomiting, constipation and diarrhea)
Primary Handling Editor: Jennifer Sargent, in collaboration with the Nature Medicine team
Compounded meds may reflect disparities in ingredients and quality, but they are typically safe when sourced from FDA-regulated 503A facilities, which Hims partners with